Beranda8AK • FRA
add
Alkermes Plc
Tutup sebelumnya
€26,80
Rentang hari
€27,40 - €27,80
Rentang tahun
€20,80 - €34,60
Kapitalisasi pasar
5,18Â M USD
Volume Rata-Rata
1,00
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 306,51Â jt | -12,52% |
Biaya operasional | 243,52Â jt | -1,97% |
Laba bersih | 22,46Â jt | -39,00% |
Margin laba bersih | 7,33 | -30,26% |
Penghasilan per saham | 0,29 | -32,33% |
EBITDA | 21,21Â jt | -58,70% |
Tarif pajak efektif | 11,87% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 884,02Â jt | 18,65% |
Total aset | 2,08Â M | -1,97% |
Total liabilitas | 570,39Â jt | -34,37% |
Total ekuitas | 1,51 M | — |
Saham yang beredar | 164,90 jt | — |
Harga terhadap nilai buku | 2,92 | — |
Tingkat pengembalian aset | 1,67% | — |
Tingkat pengembalian modal | 2,21% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 22,46Â jt | -39,00% |
Kas dari operasi | 98,81Â jt | 368,12% |
Kas dari investasi | 9,10Â jt | 122,78% |
Kas dari pembiayaan | 747,00Â rb | 104,18% |
Perubahan kas bersih | 108,66Â jt | 395,95% |
Arus kas bebas | 75,80Â jt | 536,44% |
Tentang
Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies, the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio. Wikipedia
Didirikan
1987
Situs
Karyawan
1.800
